Last reviewed: June 10, 2026
Last updated: June 10, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide dosing is measured in units, not milligrams, which can create confusion for patients starting GLP-1 therapy. Understanding how to convert 40 units to an equivalent milligram dose requires knowing your specific pen concentration, since semaglutide is available in multiple formulations. PlexusDx provides clarity on dosage conversion and personalized dosing strategies to help you achieve optimal weight loss results.
Understanding Semaglutide Unit-to-Milligram Conversion
Semaglutide is measured in units rather than milligrams in most injectable formulations, which reflects how the medication's potency is quantified for precise dosing. The standard semaglutide pens contain 2 mg per 1.5 mL of solution, meaning each unit delivers approximately 0.05 mg of active semaglutide. A 40-unit dose therefore contains approximately 2 mg of semaglutide, making this a mid-range therapeutic dose used during the dose escalation phase of treatment.
The reason for unit-based dosing stems from pharmaceutical standards that measure hormone-like compounds by their biological activity rather than weight alone. This approach ensures consistent metabolic response across different batches and formulations. Understanding this unit system is essential for tracking your dose progression and communicating accurately with your healthcare provider about your current treatment level.
Semaglutide Dose Escalation and Your Treatment Timeline
Standard semaglutide therapy follows a 4-week titration schedule, starting at 0.25 mg (5 units) and increasing by 0.25 mg increments every four weeks until reaching your maintenance dose. The 40-unit dose sits at the 2 mg level, which many patients reach by week 9-12 of treatment as their tolerance and metabolic response improve. This gradual escalation allows your body to adapt to GLP-1 receptor activation while minimizing gastrointestinal side effects and optimizing hunger suppression.
Your dose may need to go up beyond 2 mg depending on your metabolic response, weight loss plateau, or clinical goals—but your price at PlexusDx won't. All compounded semaglutide from licensed 503A pharmacies is priced at a flat rate starting at $149/month regardless of dose level, ensuring transparent, predictable costs throughout your entire treatment journey.
How PlexusDx Personalizes Your Semaglutide Dosing
Generic semaglutide dosing often follows a one-size-fits-all approach, but metabolic response varies significantly between individuals based on genetic factors, insulin sensitivity, and appetite-regulating pathways. PlexusDx uses the Precision Peptide Genetic Test to analyze key genetic variants including GLP1R rs6923761 and GIPR rs1800437, which influence how effectively your body responds to semaglutide at any given dose. This personalized data helps your provider determine whether you'll respond optimally to 40 units or whether a different dose or medication (such as tirzepatide) may yield better results.
The genetic insights from PlexusDx map across 14 metabolic pathways and 150+ clinical outcomes, giving your treatment team a complete picture of your peptide-response profile. Rather than guessing your ideal dose, precision medicine allows for faster optimization, reducing unnecessary side effects and accelerating your weight loss progress. The Precision Peptide Genetic Test is available as a $99 add-on after your first month of treatment with PlexusDx.
Compounded vs. Brand Semaglutide: Dosing and Cost Clarity
Brand semaglutide (Ozempic, Wegovy) is supplied in preset dose pens that limit flexibility, whereas compounded semaglutide from licensed 503A pharmacies can be customized to your exact dose requirements, including 40 units. PlexusDx sources all medications from licensed 503A compounding pharmacies, ensuring pharmaceutical-grade quality and purity without the premium pricing of brand-name products. This means you access medical-grade semaglutide at transparent, flat pricing starting at $149/month.
Cost is a significant barrier to GLP-1 therapy for many patients, especially since brand medications often cost $900–$1,500 monthly without insurance coverage. PlexusDx eliminates this barrier by offering compounded semaglutide nationwide without requiring insurance, membership fees, or flat per-compound pricing increases. All orders are HSA and FSA eligible, further reducing your out-of-pocket expense while accessing the same active pharmaceutical ingredient as brand alternatives.
Side Effects and Safety at the 40-Unit Dosage Level
At 40 units (2 mg), semaglutide is generally well tolerated by most patients, though gastrointestinal side effects such as nausea, vomiting, or diarrhea may occur, particularly if you escalated too quickly or have underlying gastroparesis. These effects typically diminish within 1–2 weeks as your body adapts to GLP-1 receptor stimulation. Staying hydrated, eating smaller meals, and avoiding high-fat foods can significantly reduce nausea and improve tolerability during this dose phase.
Rare but serious side effects include pancreatitis, gallbladder complications, and thyroid concerns; however, these occur at low frequency in clinical trials and are not unique to semaglutide alone. All GLP-1 medications carry a black-box warning regarding a personal or family history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2 (MEN2), making pre-treatment screening essential. Your PlexusDx provider will review your full medical history before prescribing to ensure semaglutide is appropriate for your individual health profile.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
What is the exact milligram equivalent of 40 units of semaglutide?
40 units of semaglutide equals approximately 2 mg, calculated from the standard 2 mg per 1.5 mL formulation where each unit delivers 0.05 mg. This is a common maintenance dose reached around week 9–12 of standard titration therapy. PlexusDx can verify your exact dose conversion and explain how it aligns with your personalized treatment plan.
Is 40 units a typical maintenance dose for weight loss?
Yes, 2 mg (40 units) is within the typical therapeutic range for weight loss, though some patients require higher doses and others respond optimally at lower levels. Clinical trials show significant weight reduction beginning at 1 mg and increasing further at 2 mg and higher doses. Your optimal dose depends on your metabolic genetics, which PlexusDx can clarify through the Precision Peptide Genetic Test.
Will my PlexusDx price increase if my doctor raises my semaglutide dose beyond 40 units?
No—PlexusDx pricing is flat at $149/month regardless of dose level, so any increase in your semaglutide dose carries no additional cost. This transparent pricing model eliminates the financial burden that typically comes with dose escalation on brand or insurance-covered medications.
How do I know if 40 units is the right dose for me?
The right dose depends on your weight loss progress, side effect tolerance, and individual metabolic response—not a standard protocol. The Precision Peptide Genetic Test identifies your GLP1R and GIPR variants to predict how responsive you'll be at different dose levels, helping your PlexusDx provider optimize your therapy faster and more effectively.
Can compounded semaglutide be dosed at 40 units like brand pens?
Yes—compounded semaglutide from licensed 503A pharmacies offers dose flexibility that brand pens cannot match, allowing precise 40-unit dosing and any other dose your provider prescribes. PlexusDx compounds semaglutide to your exact clinical needs without preset dose limitations, all at a flat $149/month starting price.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
The Evolution of GLP-1 Agonists: When Were They Approved?
Understanding the Monthly Cost of Compounded Semaglutide: What You Need to Know